Medable vs Medidata eCOA(eCOA)

Sponsors, CROs and academic research teams choosing an eCOA platform for a regulated clinical trial.

Scope Electronic clinical outcome assessment (eCOA) platforms that capture patient-reported (ePRO), clinician-reported, observer-reported and performance outcomes in regulated clinical trials, as a sponsor, CRO or academic research team would shortlist them.

Guide updated How we compare

Compare within eCOA

Study fit, side by side

These notes describe the products in the eCOA guide.

Medable

Best for
Sponsors and CROs that want a no-code eCOA build tool with eConsent and televisits on one platform
What to consider
Medable pairs a large library (400+ validated instruments, 120+ locales) with Study Studio, a no-code builder its site says takes studies live in 4 to 6 weeks. It publishes Part 11, Annex 11, HIPAA and GDPR compliance but no regulatory approval counts or prices.
Read product profile

Medidata eCOA

Best for
Large sponsors and CROs that already run Rave EDC and want eCOA in the same platform
What to consider
Medidata eCOA lists 2,500+ COAs, 200+ languages and dialects and 1,600+ studies, and data flows straight into Rave EDC. Study builders can configure it in Medidata Designer, with an average study start of 8 weeks. Prices are not published.
Read product profile

Compare the features

Both products use the same category definitions. Product order is editorial; products are not ranked.

Full eCOA feature comparison

Single and double checks describe documented support for an individual feature. Double checks use the extended definition for that feature. Unknown means the available evidence does not establish support.

Expand a feature definition or support note for context and its original source.

Medable vs Medidata eCOA (eCOA): category feature evidence and sources. Products are not ranked.
Category featureMedableMedidata eCOA
Validated instrument library and licensing
Feature definitions
Supported
A library of outcome-assessment instruments is documented.
Extended support
A validated or instrument-author-approved library plus managed instrument licensing are documented.
Supported

400+ pre-built, validated instruments in a reusable library with AI-assisted instrument generation; licensing services are not described on the pages checked.

Source
About this support label

A validated library is documented; licensing services are not described.

Extended support

2,500+ COAs and a global instrument library for reusing builds and translations; Medidata also offers a validated instrument license management service.

Source
About this support label

A reusable instrument library is paired with a validated instrument license-management service.

Regulatory compliance and track record
Feature definitions
Supported
Relevant trial or security controls are stated.
Extended support
Relevant trial controls plus a public ISO/SOC certificate or audit report are documented; a certification claim or logo alone is insufficient.
Supported

States compliance with 21 CFR Part 11, Annex 11, HIPAA, GDPR and ICH GCP and says its eCOA data can support primary endpoints in pivotal studies; deployed in nearly 400 trials, with no approval counts published.

Source
Supported

Medidata says its AI functionality supports 80% of 2025 FDA novel drug approvals (company-wide platform claim, not eCOA alone); position statements on Part 11, Annex 11 and ICH E6 are published.

Source
About this support label

Part 11, Annex 11 and ICH E6 statements are documented; the approval claim is company-wide.

Global scale and languages
Feature definitions
Supported
Multicountry use or multilingual/localized participant support is documented.
Extended support
Both multicountry use and multilingual/localized participant support are documented.
Extended support

80+ countries and 120+ locales; device logistics from six global depots to 65+ countries.

Source
About this support label

The note documents deployment across countries and localized participant support.

Supported

200+ languages and dialects, 1,600+ eCOA studies, 90K+ sites and 460+ sponsors.

Source
About this support label

Languages and study volumes are documented; this note does not establish multicountry use.

Capture modes and integrations
Feature definitions
Supported
Electronic outcome capture and a connection to another trial system or device are documented.
Extended support
Capture on participant-owned and provisioned devices plus wearable or sensor integration are documented.
Extended support

eCOA, eConsent, TeleVisit and devices in one platform, BYOD or provisioned, with sensors and connectors to other clinical systems.

Source
About this support label

BYOD and provisioned devices are documented alongside sensors and clinical-system connectors.

Supported

BYOD (iOS, Android), provisioned devices and web; data flows into Rave EDC; Sensor Cloud is listed among Patient Cloud applications.

Source
About this support label

BYOD, provisioned devices and Rave data flow are documented; listing Sensor Cloud does not establish sensor integration.

Time to launch and self-service build
Feature definitions
Supported
A study build process, self-service builder or launch timeframe is documented.
Extended support
Study teams can configure the study themselves, with a stated build or launch timeframe.
Supported

Study Studio is a no-code visual builder; studies that took 16 to 20 weeks go live in 4 to 6 weeks, some in a day.

Source
About this support label

A no-code builder and launch timing are documented; study-team self-service is not explicit.

Extended support

Medidata Designer lets study builders configure questionnaires with drag-and-drop templates; average study start 8 weeks versus a 12-week industry standard.

Source
About this support label

Study builders configure questionnaires in Designer, with an average eight-week study start.

Published pricing and terms
Feature definitions
Supported
A production pricing basis, model or contract terms beyond a sales contact are published.
Extended support
Numerical production prices or a free production option with its conditions are published.
Supported

Platform prices not published; device provisioning is described as one all-inclusive monthly rate, without an amount.

Source
About this support label

A monthly device-provisioning model is described; platform prices are not published.

Supported

No prices published; Medidata's public Patient Cloud service descriptions set out contract terms, such as devices provisioned on a rental basis, caps on fee adjustments and early-termination fees.

Source

The guide update date reflects guide edits. Vendor statements are attributed in the evidence.

Keep the category in view

Compare these products with the other tools in the eCOA guide using the same feature definitions.

More eCOA comparisons featuring one of these products.